Theranostic multimodular potential of zinc-doped ferrite-saturated metal-binding protein-loaded novel nanocapsules in cancers

References

• PatraHKTurnerAPThe potential legacy of cancer nanotechnology: cellular selectionTrends Biotechnol2014321213124246361
   PubMedGoogle Scholar
• KanwarJRMahidharaGKanwarRKAntiangiogenic therapy using nanotechnological-based delivery systemDrug Discov Today2011165–618820221262383
   PubMed Web of Science ®Google Scholar
• KanwarJRKamalapuramSKKanwarRKSurvivin signaling in clinical oncology: a multifaceted dragonMed Res Rev201333476578922688671
   PubMed Web of Science ®Google Scholar
• WangZLiuGZhengHChenXRigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunitiesBiotechnol Adv201432483184324013011
   PubMed Web of Science ®Google Scholar
• WangZNiuGChenXPolymeric materials for theranostic applicationsPharm Res20143161358137623765400
   PubMed Web of Science ®Google Scholar
• KanwarJRPalmanoKPSunX‘Iron-saturated’ lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapyImmunol Cell Biol200886327728818268518
   PubMed Web of Science ®Google Scholar
• KanwarJRMahidharaGKanwarRKNovel alginate-enclosed chitosan-calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapyNanomedicine (Lond)20127101521155022734611
   PubMed Web of Science ®Google Scholar
• KanwarJRMahidharaGRoyKFe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zincNanomedicine (Lond)2015101355525017148
   PubMed Web of Science ®Google Scholar
• KanwarJRKamalapuramSKKanwarRKTargeting survivin in cancer: the cell-signalling perspectiveDrug Discov Today20111611–1248549421511051
   PubMed Web of Science ®Google Scholar
• MahidharaGKanwarRKRoyKKanwarJROral administration of iron-saturated bovine lactoferrin-loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolismInt J Nanomedicine2015104081409826124661
   PubMed Web of Science ®Google Scholar
• PatraHKKhaliqNURomuTMRI-visual order-disorder micellar nanostructures for smart cancer theranosticsAdv Healthc Mater20143452653523983185
   PubMedGoogle Scholar
• KanwarJRKamalapuramSKKrishnakumarSKanwarRKMultimodal iron oxide (Fe3O4)-saturated lactoferrin nanocapsules as nanotheranostics for real-time imaging and breast cancer therapy of claudin-low, triple-negative (ER-/PR-/HER2-)Nanomedicine (Lond)201611324926826785603
   PubMed Web of Science ®Google Scholar
• US Food Drug Administration. [homepage on the internet]Guidance for Industry: A Food Labeling Guide (14. Appendix F: Calculate the Percent Daily Value for the Appropriate Nutrients) Available from: http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/LabelingNutrition/ucm064928.htmAccessed November 10, 2015
   Google Scholar
• MekswanKSermesriUChanvorchotePZinc supplementation improves anticancer activity of monocytes in type-2 diabetic patients with metabolic syndromeAnticancer Res201434129529924403477
   PubMedGoogle Scholar
• TsengYCKulpSLaiILPreclinical investigation of the novel histone deacetylase (HDAC) inhibitor AR-42 in the treatment of cancer-induced cachexiaJ Natl Cancer Inst201510712274
   Google Scholar
• ShinJCarrACornerGAThe intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent mannerJ Biol Chem201428936253062531625037223
   PubMedGoogle Scholar
• LiHChiappinelliKBGuzzettaAAImmune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancersOncotarget20145358759824583822
   PubMedGoogle Scholar
• AgarwalVRBhatiaDJoshiAP7170, a novel inhibitor of phosphoinositide 3-kinase (PI3K)-mammalian target of rapamycin (mTOR) and activin receptor-like kinase 1 (ALK1) shows anti-tumor activity in triple negative breast cancerCancer Res20147419 Supplement4521
   Google Scholar
• TanYSunDJiangWPP2A-B55β antagonizes cyclin E1 proteolysis and promotes its dysregulation in cancerCancer Research20147472006201424509904
   PubMedGoogle Scholar
• MarraPMathewSGrigoriadisAIL15RA drives antagonistic mechanisms of cancer development and immune control in lymphocyte-enriched triple-negative breast cancersCancer Res201474174908492124980552
   PubMedGoogle Scholar
• KanwarRKGangulyNKKumarLRakeshJPanigrahiDWaliaBNCalcium and protein kinase C play an important role in Campylobacter jejuni-induced changes in Na+ and Cl− transport in rat ileum in vitroBiochim Biophys Acta199512702–31791927727542
   PubMed Web of Science ®Google Scholar
• ChakravartyPKEvaluation of serum zinc level under malignant condition and its possible implication on improving cell-mediated immunity during cancer progressionWorld J Oncol2011211623
   PubMedGoogle Scholar
• ShahBPPasqualeNDeGTanTMaJLeeKBCore-shell nanoparticle-based peptide therapeutics and combined hyperthermia for enhanced cancer cell apoptosisACS Nano2014899379938725133971
   PubMedGoogle Scholar
• LeeSYJeonSIJungSChungIJAhnCHTargeted multimodal imaging modalitiesAdv Drug Deliv Rev201476607825064554
   PubMed Web of Science ®Google Scholar
• KanwarRKKanwarJRImmunomodulatory lactoferrin in the regulation of apoptosis modulatory proteins in cancerProtein Pept Lett201320445045823016584
   PubMed Web of Science ®Google Scholar
• MocchegianiEMalavoltaMGiacconiRCostarelliLDietary intake and impact of zinc supplementation on the immune functions in elderly: nutrigenomic approachMassoudARezaeiNImmunology of AgingHeidelbergSpringer2014295308
   Google Scholar
• GibbonsJAKanwarJRKanwarRKIron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancerBMC Cancer20151542510.1186/s12885-015-1441-425998617
   PubMed Web of Science ®Google Scholar
• LaurentSSaeiAABehzadiSPanahifarAMahmoudiMSuperparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challengesExpert Opin Drug Deliv20141191449147024870351
   PubMed Web of Science ®Google Scholar
• ImaiKBeppuTYamaoTClinicopathological and prognostic significance of preoperative serum zinc status in patients with hepatocellular carcinoma after initial hepatectomyAnn Surg Oncol201421123817382624841354
   PubMedGoogle Scholar
• DegirolamoCSabbàCMoschettaAIntestinal nuclear receptors in HDL cholesterol metabolismJ Lipid Res20155671262127025070952
   PubMedGoogle Scholar
• ArriagaJMGrecoAMordohJBianchiniMMetallothionein 1G and zinc sensitize human colorectal cancer cells to chemotherapyMol Cancer Ther20141351369138124634414
   PubMed Web of Science ®Google Scholar
• HarmazaYMSlobozhaninaEIZinc essentiality and toxicity: biophysical aspectsBiofizika2014592264275 Russian
   Google Scholar
• AkhavanOMeidanchiAGhaderiEKhoeiSZinc ferrite spinel-graphene in magneto-photothermal therapy of cancerJ Mater Chem B Mater Biol Med201422133063314
   PubMed Web of Science ®Google Scholar
• LeeHJSanetuntikulJChoiESPhotothermal cancer therapy using graphitic carbon-coated magnetic particles prepared by one-pot synthesisInt J Nanomedicine20151027128225565819
   PubMedGoogle Scholar
• CoxJDStetzJPajakTFToxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)Int J Radiat Oncol Biol Phys1995315134113467713792
   PubMed Web of Science ®Google Scholar
• RodgersGM3rdBeckerPSBlinderMCancer- and chemotherapy-induced anemiaJ Natl Compr Canc Netw201210562865322570293
   PubMed Web of Science ®Google Scholar
• SchwartzRNAnemia in patients with cancer: incidence, causes, impact, management, and use of treatment guidelines and protocolsAm J Health Syst Pharm2007643 Suppl 2S5S13 quiz S28–S3017244886
   PubMed Web of Science ®Google Scholar
• SpivakJLGascónPLudwigHAnemia management in oncology and hematologyOncologist200914Suppl 1435619762516
   PubMed Web of Science ®Google Scholar
• CaltagironeCFalchiAMLampisSCancer-cell-targeted theranostic cubosomesLangmuir201430216228623624815031
   PubMedGoogle Scholar
• CondeJBaoCCuiDBaptistaPVTianFAntibody-drug gold nanoantennas with Raman spectroscopic fingerprints for in vivo tumour theranosticsJ Control Release2014183879324704711
   PubMed Web of Science ®Google Scholar
• KanwarRKChaudharyRTsuzukiTKanwarJREmerging engineered magnetic nanoparticulate probes for molecular MRI of atherosclerosis: how far have we come?Nanomedicine (Lond)20127689991622715913
   PubMedGoogle Scholar
• KiesslingFFokongSBzylJLederleWPalmowskiMLammersTRecent advances in molecular, multimodal and theranostic ultrasound imagingAdv Drug Deliv Rev201472152724316070
   PubMed Web of Science ®Google Scholar
• LeungAWKalraJSantosNDBallyMBAnglesioMSHarnessing the potential of lipid-based nanomedicines for type-specific ovarian cancer treatmentsNanomedicine (Lond)20149350152224746193
   PubMed Web of Science ®Google Scholar
• KanwarJRShankaranarayananJSGurudevanSKanwarRKAptamer-based therapeutics of the past, present and future: from the perspective of eye-related diseasesDrug Discov Today20141991309132124598791
   PubMedGoogle Scholar